Table 5 |
|||||
|
Anti-collagen type II antibody responses in C6, C9, C10 and C11 congenic mice |
|||||
|
Antibody isotype |
B10.RIIIa |
C6 |
C9 |
C10 |
C11 |
|
|
|||||
|
IgG1 |
2046b ± 276c |
1567 ± 265 |
1354 ± 193 |
2520 ± 388* |
2868 ± 576* |
|
IgG2c |
2337 ± 262 |
1754 ± 212 |
2031 ± 420 |
2859 ± 477 |
4096 ± 692** |
|
IgG3 |
1873 ± 141 |
1364 ± 273 |
2144 ± 473 |
2483 ± 370 |
3021 ± 409** |
|
IgTot |
2705 ± 300 |
2038 ± 291 |
2439 ± 661 |
4130 ± 551** |
3696 ± 543** |
|
|
|||||
|
aB10.RIII = littermate controls (n = 64) for mice with the different congenic fragments. The congenic intervals are outlined in Figure 5a. C6 (n = 14), C9 (n = 9), C10 (n = 15), C11 (n = 17). bArbitrary antibody concentration in serum. Blood was collected day 21 after immunisation. Anti-collagen type II antibodies in non-immunized mice are not detectable. cMean ± standard error of the mean Statistics was calculated with Mann-Whitney U test, * p < 0.05, **p < 0.01 |
|||||
|
Lindvall et al. Arthritis Research & Therapy 2009 11:R10 doi:10.1186/ar2597 |
|||||